Creative Biolabs is looking for potential partners (include but not limit to major pharma or biotech firms) to develop anti-SOCS3 therapeutic monoclonal antibody program together. Our scientists are dedicated to bringing years of valuable experience to our partner and achieve a meaningful partnership. For any partners interest in our Next-IO™ programs, Creative Biolabs welcomes collaboration.
Learn more about Next-IO™ Anti-SOCS3 Therapeutic Monoclonal Antibody Program: https://www.creative-biola...
#health #biotech

Only people mentioned by catalinagarcia in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Catalina Garcia, click on at the bottom under it